摘要
目的观察与分析阿莫西林联合果胶铋在慢性萎缩性胃炎疾病治疗中的临床运用效果。方法依据患者自愿原则,将94例慢性萎缩性胃炎患者成分研究组（47例）与对照组（47例）,前者予以阿莫西林＋果胶铋治疗,后者予以克拉霉素＋果胶铋治疗;观察与比较两组患者的临床疗效。结果研究组患者治疗后的有效率（93.6%）比对照组患者（76.6%）高,差异有统计学意义（P〈0.05,χ-2=8.115）;研究组患者复发率（6.4%）低于对照组（12.8%）,差异有统计学意义（P〈0.05,χ-2=7.361）。结论采取阿莫西林联合果胶铋治疗慢性萎缩性胃炎,效果显著,且复发率低。
Objective To observe and analyze the clinical effect of amoxicillin and bismuth pectin bismuth in treatment of chronic atrophic gastritis. Methods According to the principle of voluntary patients,94 cases of chronic atrophic gastritis patients composition study group（47 cases）and control group（47 cases）,the former treated with amoxicillin and bismuth pectin,the latter to be clarithromycin and colloidal bismuth pectin treatment,and compared between the two groups of patients with clinical curative effect observation. Results The effective rate of the study group（93.6%）was significantly higher than that in the control group（76.6%）,the difference was statistically significant（P〈0.05,χ-2=8.115）,recurrence rate of the study group（6.4%）was lower than that of the control group（12.8%）,the difference was statistically significant（P〈0.05,χ-2=7.361）. Conclusion The effect of amoxicillin combined with bismuth pectin bismuth on chronic atrophic gastritis is significant,and the recurrence rate is low.
出处
《中国卫生标准管理》
2016年第1期138-139,共2页
China Health Standard Management
关键词
慢性萎缩性胃炎
阿莫西林
果胶铋
Chronic atrophic gastritis
Amoxicillin capsules
Pectic bismuth
